Form 4: CalciMedica Director Frederic Guerard Acquires 10,000 Stock Options
SEC Form 4 Filing
Director Frederic Guerard acquired 10,000 stock options in CalciMedica, Inc. at an exercise price of $4.16 on August 27, 2024.
Summary
- On August 27, 2024, Frederic Guerard, a director of CalciMedica, Inc., acquired 10,000 stock options.
- The exercise price of these options is $4.16.
- The options vest monthly over a one-year period starting March 28, 2024.
- The options expire on August 26, 2034.
- Following the transaction, Guerard directly owns 10,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction. The acquisition of stock options by a director is generally viewed as a positive, but it's not a major event.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Start date for monthly vesting of stock options. |
| August 27, 2024 | Date of transaction: Frederic Guerard acquired stock options. |
| August 28, 2024 | Date of filing. |
| August 26, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.